Rotavirus epidemiology: the Asian Rotavirus Surveillance Network
E A S Nelson,J S Bresee,U D Parashar,M-A Widdowson,R I Glass,Asian Rotavirus Surveillance Network,Zhao-Yin Fang,Bei Wang,Li-Jie Zhang,Li-Wei Sun,Zeng-Qing Du,Jing-Yu Tang,An-Cun Hou,Hui Shen,Xiao-Bo Song,Xuan-Yi Wang,Zhi-Yi Xu,Ying-Lin Zhang,Shou-Jun Zhao,Zhi-Yong Hao,Zhan-Chun Xing,Chang-Quan Han,Jing-Chen Ma,Ji-Chao Chen,John S Tam,Paul K S Chan,Ly-Mee Yu,Ying-Chu Ng,Kin-Hung Poon,Chi-Hang Ng,Kin-Sing Ip,Tai-Fai Fok,Rajiv Bahl,Pratima Ray,Swati Subodh,Prashant Shambharkar,Manju Saxena,M K Bhan,Gagandeep Kang,Shobhana D Kelkar,Shoba D Chitambar,Trailokyanath Naik,Yati Soenarto,Siswanto Agus Wilopo,Abu Tholib Aman,Mega,Rully,Bachryan Eljuta,Nenny Sri Mulyani,Toyoko Nakagomi,Osamu Nakagomi,Yoshihiro Takahashi,Masamichi Enoki,Takashi Suzuki,Jung S Kim,Jung O Kang,Soo C Cho,Young T Jang,Sae A Min,Tae H Park,Dae S Jo,Paul E Kilgore,Batmunkh Nyambat,Zhi Y Xu,Lorenz von Seidlein,Oak Pil Han,John Clemens,Hasan bin Abdul Rahman,Swee Lan Wong,Lailanor H J Ibrahim,Ahmad Faudzi H J Yusoff,Lee Gaik Chan,Kyaw Moe,Win Mar Oo,Thandar Lwin,Tin Tin Htwe,Kow-Tong Chen,Po-Yen Chen,Ren-Bin Tang,Yung-Feng Huang,Ping-Ing Lee,Jyh-Yuan Yang,Hour-Young Chen,Chuleeporn Jiraphongsa,Yaowapa Pongsuwanna,Pipat Kluabwang,Urai Poonawagul,Pramote Arporntip,Manas Kanoksil,Nakorn Premsri,Utcharee Intusoma,Nguyen Van Man,Le Thi Luan,Dang Duc Trach,Nguyen Thi Hien Thanh,Phan Van Tu,Nguyen Thanh Long,Dang Duc Anh,Erik Hummelman,Jon R Gentsch,Thea K Fischer,Vincent P Hsu,Ashley R Laird,Brittany Bielfelt,Dixie D Griffin,Madhu Ramachandran,Vivek Jain,Baoming Jiang,Laura Jean Podewils,Lynn Antil,Richard Rheingans,T Christopher Mast,Bernard Ivanoff,Duncan Steele,Carl D Kirkwood,Krisztiain Bai Nyai,Nigel A Cunliffe
DOI: https://doi.org/10.1016/j.vaccine.2008.03.073
IF: 4.169
2008-06-19
Vaccine
Abstract:Availability of new rotavirus vaccines has highlighted the need to collect local disease and economic burden data to aid decision makers at global, regional and country level. The World Health Organization and the GAVI Alliance recommended that generic protocols be used and that regional surveillance networks be established to collect these data, thereby helping to fast-track the introduction of these new vaccines into developing countries. Nine countries and regions participated in the first phase of the Asian Rotavirus Surveillance Network (ARSN), which collected data over a 2-year period during 2001-2003. Overall 45% of diarrhoea admissions in the region were positive for rotavirus, which was higher than had been anticipated. Significant rotavirus strain diversity was noted during the surveillance period. Data collection for a second phase of the ARSN commenced in 2004 and included a greater proportion of poorer countries that would in future be eligible for funding support for rotavirus immunization from GAVI. Limited economic evaluations in Asia have demonstrated the potential for new rotavirus vaccines to be cost-effective but more local analyses are required. Despite the ARSN's comprehensive data from a mix of developed and developing countries, Asia has lagged the Americas in terms of the introduction of rotavirus vaccines into National Immunization Programmes (NIPs). Lack on rotavirus vaccine efficacy data in Asia, particularly in poorer populations, will have contributed to this delay. Thus ensuring that all global regions are simultaneously involved in the evaluation of new vaccines from the beginning and also encouraging more regional collaborations of Ministry of Health representatives could help to accelerate the introduction of new vaccines into NIPs.